Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling

Background: The aim of this study was to explore the combined efficacy ofeffective-component compatibility of Bufei Yishen formula III (ECC-BYF III) and exercise rehabilitation (ER) in inhibiting airway mucus hypersecretion in a chronic obstructive pulmonary disease (COPD) rat model. Methods: A tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Kexin, Ma, Jindi, Lu, Ruilong, Shao, Xuejie, Zhao, Yakun, Cui, Lili, Qiu, Zhiguang, Tian, Yange, Li, Jiansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2023
Materias:
Respiratory System
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643050/
https://www.ncbi.nlm.nih.gov/pubmed/36799253
http://dx.doi.org/10.1042/BSR20222669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643050/
https://www.ncbi.nlm.nih.gov/pubmed/36799253
http://dx.doi.org/10.1042/BSR20222669

Ejemplares similares